Unbound fraction of vancomycin in intensive care unit patients

Journal of Clinical Pharmacology

Volumn 54, Issue 3, 2014, Pages 318-323

  Kees, Martin G ^a,b   Wicha, Sebastian G ^b   Seefeld, Astrid ^c   Kees, Frieder ^c   Kloft, Charlotte ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

antibiotics; HPLC; hypoalbuminemia; protein binding; ultrafiltration

Indexed keywords

ALBUMIN; HUMAN SERUM ALBUMIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTENT VALIDITY; CONTINUOUS INFUSION; CREATININE CLEARANCE; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENSIVE CARE UNIT; MALE; PH; PROTEIN BINDING; TEMPERATURE; ULTRAFILTRATION;

ANTIBIOTICS; HPLC; HYPOALBUMINEMIA; PROTEIN BINDING; ULTRAFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; SERUM ALBUMIN; TEMPERATURE; ULTRAFILTRATION; VANCOMYCIN;

EID: 84898659907     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.175     Document Type: Article

References (26)

1. Zeitlinger MA, Derendorf H, Mouton JW, et al. Protein binding: Do we ever learn ? Antimicrob Agents Chemother 2011; 55: 3067-3074.
2. Roberts JA, Pea F, Lipman J., The clinical relevance of plasma protein binding changes. Clin Pharmacokinet 2013; 52, 1-8. doi: 10.1007/s40262-012-0018- 5
3. Patel N, Pai MP, Rodvold KA, Lomaestr B, Drusano GL, Lodise TP., Vancomycin: We can't get there from here. Clin Infect Dis 2011; 52, 969-974. doi: 10.1093/cid/cir078
4. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66, 82-98. doi: 10.2146/ajhp080434
5. Berthoin K, Ampe E, Tulkens PM, Carryn S., Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections. Int J Antimicrob Agents 2009; 34, 555-560.
6. Butterfield JM, Patel N, Pai MP, Rosano TG, Drusano GL, Lodise TP., Refining vancomycin protein binding estimates: Identification of clinical factors that influence protein binding. Antimicrob Agents Chemother 2011; 55, 4277-4282. doi: 10.1128/AAC;1; 01674-10
7. Ampe E, Delaere B, Hecq J-D, Tulkens PM, Glupczynski Y., Implementation of a protocol for administration of vancomycin by continuous infusion: Pharmacokinetic, pharmacodynamic and toxicological aspects. Int J Antimicrob Agents 2013; 41, 439-446. doi: 10.1016/j.ijantimicag.2013.01.009
8. Crandon JL, MacVane SH, Nicolau DP., Clinical laboratory-based assay methodologies may underestimate and increase variability of vancomycin protein binding in hospitalized patients. Pharmacotherapy 2013; doi: 10.1002/phar.1323
9. Kees MG, Hilpert JW, Gnewuch C, Kees F, Voegeler S., Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: Correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents 2010; 36, 545-548. doi: 10.1016/j.ijantimicag.2010. 07.015
10. Blanchard J, Harvey S., Comparison of ultrafiltration devices for assessing theophylline protein binding. Ther Drug Monit 1990; 12, 398-403. (Pubitemid 20240648)
11. Whitlam JB, Brown KF., Ultrafiltration in serum protein binding determinations. J Pharm Sci 1981; 70, 146-150. (Pubitemid 11131216)
12. Kees MG, Vögeler S, Hilpert JW., Initial dosing of vancomycin in critically ill patients. Int J Antimicrob Agents 2011; 38, 91-92. doi: 16/j.ijantimicag.2011.03.009
13. Høstmark E, Glattre E, Jellum AT., Effect of long-term storage on the concentration of albumin and free fatty acids in human sera. Scand J Clin Lab Invest 2001; 61, 443-447. doi: 10.1080/00365510152567077 (Pubitemid 32900431)
14. Cantú TG, Dick JD, Elliott DE, Humphrey RL, Kornhauser DM., Protein binding of vancomycin in a patient with immunoglobulin A myeloma. Antimicrob Agents Chemother 1990; 34, 1459-1461. (Pubitemid 20215796)
15. Tan CC, Lee HS, Ti TY, Lee EJ., Pharmacokinetics of intravenous vancomycin in patients with end-stage renal failure. Ther Drug Monit 1990; 12, 29-34. (Pubitemid 20034684)
16. Chen Y, Norris RLG, Schneider JJ, Ravenscroft PJ., The influence of vancomycin concentration and the pH of plasma on vancomycin protein binding. J Pharmacol Toxicol Methods 1992; 28, 57-60.
17. Sun H, Maderazo EG, Krusell AR., Serum protein-binding characteristics of vancomycin. Antimicrob Agents Chemother 1993; 37, 1132-1136. (Pubitemid 23141332)
18. Rodvold KA, Blum RA, Fischer JH, et al. Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother 1988; 32, 848-852.
19. Zokufa HZ, Solem LD, Rodvold KA, Crossley KB, Fischer JH, Rotschafer JC., The influence of serum albumin and alpha 1-acid glycoprotein on vancomycin protein binding in patients with burn injuries. J Burn Care Rehabil 1989; 10, 425-428. (Pubitemid 19250620)
20. Kochansky, CJ, McMasters DR, Lu P, et al. Impact of pH on plasma protein binding in equilibrium dialysis. Mol Pharmaceutics 2008; 5, 438-448. (Pubitemid 351929828)
21. Fura A, Harper TW, Zhang H, Fung L, Shyu WC., Shift in pH of biological fluids during storage and processing: Effect on bioanalysis. J Pharm Biomed Anal 2003; 32, 513-522. doi: 10.1016/S0731-7085(03)00159-6 (Pubitemid 38021842)
22. Judd RL, Pesce AJ., Free drug concentrations are constant in serial fractions of plasma ultrafiltrate. Clin Chem 1982; 28, 1726-1727. (Pubitemid 12090706)
23. Shin WG, Lee MG, Lee MH, Kim ND., Factors influencing the protein binding of vancomycin. Biopharm Drug Dispos 1991; 12, 637-646.
24. Jusko WJ, Gretch M., Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab Rev 1976; 5, 43-140.
25. Schmidt S, Gonzalez D, Derendorf H., Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci 2010; 99, 1107-1122. doi: 10.1002/jps.21916
26. Morita K, Yamaji A., Changes in the serum protein binding of vancomycin in patients with methicillin-resistant Staphylococcus aureus infection: The role of serum alpha 1-acid glycoprotein levels. Ther Drug Monit 1995; 17, 107-112.